DTC Ad Final Rule Means Reliance On PhRMA Program Risks Enforcement Action – Azar
Executive Summary
Nevertheless, the Pharmaceutical Research and Manufacturers of America announces enhancement of its voluntary drug pricing disclosures program, a Medicines Assistance Tool website that links to individual company sites, in response to the US rule.
You may also be interested in...
DTC Ad Proposal: Biopharma, Advertisers Marshall Legal Arguments In Opposition
Industry comments urge CMS to withdraw proposed rule mandating list price disclosures in TV ads, citing legal conflicts.
Trump Administration's Rx Drug Price Disclosure Reg Seen As Unworkable
Lawyers say CMS proposed rule requiring TV ads to disclose drug's list price wouldn't survive First Amendment suit and competitors have no reason to try to enforce it.
Trump Administration's Rx-Price-Disclosure Reg Sets Up Legal Fight With PhRMA
From kinds of ads targeted to agency that's issuing the reg, policy seems designed to withstand a court challenge.